← Back to Search

Behavioral Intervention

Horizons Digital Health Application Group for Quality of Life

N/A
Waitlist Available
Led By Lara Traeger, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Underwent allogeneic hematopoietic stem cell transplant
* Have moderate to severe chronic graft-versus-host disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8-week follow-up
Awards & highlights
No Placebo-Only Group

Summary

The goal of this interventional study is to learn if the Horizons mobile application is feasible for survivors of allogeneic hematopoietic stem cell transplant who have chronic graft-versus-host disease. Participants will be asked to complete surveys and use the Horizons mobile application.

Who is the study for?
This trial is for survivors of allogeneic hematopoietic stem cell transplant who are living with chronic graft-versus-host disease. Participants should be willing to complete surveys and use the Horizons mobile application.
What is being tested?
The study is testing whether the Horizons app can help improve quality of life for people with chronic graft-versus-host disease after a stem cell transplant. It involves using the app and completing surveys about their experience.
What are the potential side effects?
Since this trial involves a digital health intervention, there are no direct medical side effects associated with traditional medications or procedures. However, users may experience stress or frustration if they encounter technical difficulties.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8-week follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of participant enrollment
Percentage of participant retention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Horizons Digital Health Application GroupExperimental Treatment1 Intervention
Participants will receive the Horizons mobile application for up to 6 weeks.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
949 Previous Clinical Trials
428,444 Total Patients Enrolled
Lara Traeger, PhDPrincipal InvestigatorUniversity of Miami
4 Previous Clinical Trials
423 Total Patients Enrolled
~13 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top